Confronted by Trump, Denmark Looks to Its European Neighbors for Support
The prime minister does a European tour while announcing more spending on security around the island, following President ...
Outsourcing-pharma2d
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
Denmark increasing military spending amid Trump Greenland acquisition talk
Denmark this week announced a $2 billion security package for Greenland, making another large commitment to the defense of ...
Novo Nordisk next-gen shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...